GSK announces more layoffs, 180 affected in North Carolina

by Bill Fester on March 31, 2015

in Industries, Jobs, People, Pharmaceutical

from Triangle Business Journal

by Jason DeBruyn

 
GSK announces more layoffs, 180 affected in North Carolina
Mar 23, 2015, 5:05pm EDT Updated: Mar 23, 2015, 5:07pm EDT
Share on Google + Share on Facebook Share on LinkedIn Share on Twitter Email this article
Save
Order Reprints
Print
GlaxoSmithKline
Enlarge Photo
John West

GSK has a more than 30-year history at Research Triangle Park.
Marvelous Governors Club Home 15 photos
Home of the Day
Sponsor Listing

Jason deBruyn
Staff Writer- Triangle Business Journal
Email | Twitter

Drug giant GlaxoSmithKline (NYSE: GSK) announced another round of layoffs Monday, this time affecting 180 workers in North Carolina.

The affected positions are in sales, marketing, operations and other managerial, technical and support roles, according to a Worker Adjustment and Retraining Notification – WARN notice – filed with the N.C. Department of Commerce.

Just last week, GSK announced 150 layoffs in Pennsylvania. Last year, GSK announced plans to lay off 900 workers from its operations in Research Triangle Park, though a significant portion of those are expected to find work with Parexel, (Nasdaq: PRXL) a pharmaceutical research organization with major operations in Durham.

“The restructuring is intended to improve operational performance and contribute to a multiyear cost savings initiative across our commercial operations, global support functions as well as the R&D (research and development) and manufacturing facilities,” according to the WARN notice signed by Lisa Benna, GSK vice president of Human Resources, Pharma.

Affected employees will be offered severance, though the WARN did not go into detail.

Jason deBruyn covers the biopharmaceutical and health care industries. Follow him on Twitter @jasondebruyn.

Previous post:

Next post: